Avatrombopag for Adults with Early Versus Chronic Immune Thrombocytopenia

被引：0
|
作者：
Virk, Zain [1 ]
Leaf, Rebecca Karp [2 ]
Kuter, David J. [3 ,4 ]
Goodarzi, Katayoon [2 ]
Connell, Nathan T. [4 ,5 ]
Connors, Jean M. [6 ]
Al-Samkari, Hanny [4 ,7 ]
机构：
[1] Vanderbilt Univ, Dept Med, Med Ctr, Nashville, TN USA
[2] Massachusetts Gen Hosp, Boston, MA USA
[3] Massachusetts Gen Hosp, Div Hematol, Boston, MA USA
[4] Harvard Med Sch, Boston, MA USA
[5] Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA USA
[6] Dana Farber Canc Inst, Boston, MA USA
[7] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179601
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia
    Mingot Castellano, Maria Eva
    Pedrote Amador, Begona
    Tomasello, Riccardo
    Ghanima, Waleed
    BLOOD, 2023, 142
  • [32] Avatrombopag in the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure: a profile of its use in the USA
    Emma H. McCafferty
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 1 - 6
  • [33] Efficacy and Safety of Avatrombopag in Patients with Chronic Immune Thrombocytopenia: A Systematic Literature Review and Network Meta-Analysis
    Wojciechowski, Piotr
    Wilson, Koo
    Nazir, Jameel
    Pustulka, Iwona
    Tytula, Anna
    Smela, Beata
    Pochopien, Michal
    Vredenburg, Michael
    McCrae, Keith R.
    Jurczak, Wojciech
    ADVANCES IN THERAPY, 2021, 38 (06) : 3113 - 3128
  • [34] Avatrombopag in the treatment of thrombocytopenia in adults with chronic liver disease scheduled to undergo a procedure: a profile of its use in the USA
    McCafferty, Emma H.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (01) : 1 - 6
  • [35] Immune thrombocytopenia in adults
    Erdal Kurto?lu
    Volkan Karaku?
    World Journal of Immunology, 2014, (01) : 34 - 41
  • [36] An evaluation of avatrombopag for the treatment of thrombocytopenia
    Virk, Zain Mohammed
    Kuter, David J.
    Al-Samkari, Hanny
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (03) : 273 - 280
  • [37] Treatment practices in adults with chronic immune thrombocytopenia - a European perspective
    Rodeghiero, Francesco
    Besalduch, Juan
    Michel, Marc
    Provan, Drew
    Grotzinger, Kelly
    Thompson, Gwilym
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (02) : 160 - 168
  • [38] RITUXIMAB THERAPY FOR ADULTS WITH CHRONIC AND REFRACTORY PRIMARY IMMUNE THROMBOCYTOPENIA
    Moldovianu, A. M.
    HAEMATOLOGICA, 2012, 97 : 689 - 690
  • [39] Correction to: Avatrombopag: A Review in Thrombocytopenia
    Anthony Markham
    Drugs, 2021, 81 (18) : 2169 - 2169
  • [40] Avatrombopag maleate for the treatment of periprocedural thrombocytopenia in patients with chronic liver disease
    Al-Samkari, H.
    DRUGS OF TODAY, 2018, 54 (11) : 647 - 655
12345